Avoid concomitant use of tucatinib with CYP3A substrates, exactly where nominal concentration adjustments might bring about major or everyday living-threatening toxicities. If unavoidable, minimize CYP3A substrate dose In line with solution labeling.Drugs that involve prior authorization. This restriction requires that particular medical criteria b… Read More